Brivanib (BMS-540215)
Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Phase 3.
Supplier | Selleck Chemicals |
---|---|
Product # | S1084 |
Sku # | S1084-5mg |
Pricing | 5mg, $170.00 |